Alyeska Investment Group’s AVANIR PHARMACEUTICALS, INC CL A AVNR Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-553,190	Closed	-$9.38M	–	641
2014 Q4	$9.38M	Buy	553,190 +253,190	+84%	+$4.29M	0.16%	203
2014 Q3	$3.58M	Buy	300,000 +21,682	+8%	+$258K	0.07%	242
2014 Q2	$1.57M	Buy	+278,318	New	+$1.57M	0.03%	294